Ubs Group Ag Applied Therapeutics Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Ubs Group Ag holds 441,769 shares of APLT stock, worth $207,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
441,769
Previous 283,685
55.73%
Holding current value
$207,631
Previous $2.41 Million
84.45%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$5.41 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$4.7 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$4.52 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.14 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.12 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $22.6M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...